Cargando…
Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial
OBJECTIVE: To assess the role of antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage. MATERIALS AND METHODS: A total of 60 patients who underwent endoscopic therapy for bleeding esophageal varices were randomized into the prophylaxis group and the on-demand group. Pat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319243/ https://www.ncbi.nlm.nih.gov/pubmed/25709348 http://dx.doi.org/10.4103/0976-500X.149139 |
_version_ | 1782355929188007936 |
---|---|
author | Agarwal, Ajit Kumar, Sathasivam Suresh Sadasivan, Jagdish Kate, Vikram |
author_facet | Agarwal, Ajit Kumar, Sathasivam Suresh Sadasivan, Jagdish Kate, Vikram |
author_sort | Agarwal, Ajit |
collection | PubMed |
description | OBJECTIVE: To assess the role of antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage. MATERIALS AND METHODS: A total of 60 patients who underwent endoscopic therapy for bleeding esophageal varices were randomized into the prophylaxis group and the on-demand group. Patients in the prophylaxis group received antibiotic prophylaxis using intravenous ofloxacin till the patient resumed oral fluids, followed by oral ofloxacin tablet for a total of 7 days. In the on-demand group, antibiotics were used only when infection was evident. Patients were monitored for rebleeding and infection during the hospital stay. RESULTS: A total of 30 patients in the prophylaxis group and 26 patients in the on-demand group were analyzed. The clinical characteristics in both the groups were similar. The Child–Pugh score was around 7 in both the groups. The incidence of infection was 5/30 (16.7%) in the prophylaxis group and 7/26 (26.9%) in the on-demand group (P = 0.52). The incidence of early rebleeding in the prophylaxis vs. the on-demand group was 3 vs. 5 (P = 0.69), and the incidence of late rebleeding was 6 vs. 8 (P = 0.48). The differences were not significant. CONCLUSION: The present study shows a trend toward lower rate of early and late rebleeding, infection rate and mortality in the prophylaxis group; hence, routine use of antibiotics in all such patients may not be necessary. Further studies with a larger sample size and a longer follow-up period are required to validate the usefulness of antibiotics in these patients. |
format | Online Article Text |
id | pubmed-4319243 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43192432015-02-23 Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial Agarwal, Ajit Kumar, Sathasivam Suresh Sadasivan, Jagdish Kate, Vikram J Pharmacol Pharmacother Research Paper OBJECTIVE: To assess the role of antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage. MATERIALS AND METHODS: A total of 60 patients who underwent endoscopic therapy for bleeding esophageal varices were randomized into the prophylaxis group and the on-demand group. Patients in the prophylaxis group received antibiotic prophylaxis using intravenous ofloxacin till the patient resumed oral fluids, followed by oral ofloxacin tablet for a total of 7 days. In the on-demand group, antibiotics were used only when infection was evident. Patients were monitored for rebleeding and infection during the hospital stay. RESULTS: A total of 30 patients in the prophylaxis group and 26 patients in the on-demand group were analyzed. The clinical characteristics in both the groups were similar. The Child–Pugh score was around 7 in both the groups. The incidence of infection was 5/30 (16.7%) in the prophylaxis group and 7/26 (26.9%) in the on-demand group (P = 0.52). The incidence of early rebleeding in the prophylaxis vs. the on-demand group was 3 vs. 5 (P = 0.69), and the incidence of late rebleeding was 6 vs. 8 (P = 0.48). The differences were not significant. CONCLUSION: The present study shows a trend toward lower rate of early and late rebleeding, infection rate and mortality in the prophylaxis group; hence, routine use of antibiotics in all such patients may not be necessary. Further studies with a larger sample size and a longer follow-up period are required to validate the usefulness of antibiotics in these patients. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4319243/ /pubmed/25709348 http://dx.doi.org/10.4103/0976-500X.149139 Text en Copyright: © Journal of Pharmacology and Pharmacotherapeutics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Agarwal, Ajit Kumar, Sathasivam Suresh Sadasivan, Jagdish Kate, Vikram Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial |
title | Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial |
title_full | Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial |
title_fullStr | Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial |
title_full_unstemmed | Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial |
title_short | Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial |
title_sort | antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: a randomized trial |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319243/ https://www.ncbi.nlm.nih.gov/pubmed/25709348 http://dx.doi.org/10.4103/0976-500X.149139 |
work_keys_str_mv | AT agarwalajit antibioticprophylaxisinthepreventionofrebleedinginacutevaricealhemorrhagearandomizedtrial AT kumarsathasivamsuresh antibioticprophylaxisinthepreventionofrebleedinginacutevaricealhemorrhagearandomizedtrial AT sadasivanjagdish antibioticprophylaxisinthepreventionofrebleedinginacutevaricealhemorrhagearandomizedtrial AT katevikram antibioticprophylaxisinthepreventionofrebleedinginacutevaricealhemorrhagearandomizedtrial |